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This study provides biochemical and electron spin resonance spectroscopic evidence that contract of 
human polymorphonuclear leukocytes with antibody-coated Trypanosoma cruzi triggers the respiratory 
burst. Oxygen consumption, superoxide anion and hydrogen peroxide release were stimulated under 
conditions of polymorphonuclear leukocyte-mediated killing. This stimulation did not occur under non- 
killing conditions when antibody was omitted. A common mechanism of cytotoxicity of human polymor- 
phonuclear leukocytes against different T. cruzi forms is suggested by the triggering of the respiratory 
burst by antibody-coated epimastigotes and trypomastigotes. 
DMPO Neutrophil Hydrogen peroxide 
1. INTRODUCTION 
Human polymorphonuclear leukocytes (PMN) 
are an important host defense mechanism against 
bacterial, fungal, viral and possible parasite inva- 
sion [l-4]. The mechanisms utilized by the PMN 
to destroy parasites are not well understood, but 
increasing attention has been focused on the ability 
of the PMN to generate potentially cytotoxic 
metabolites [S-7]. Following specific membrane 
perturbation, the PMN exhibit a burst in oxygen 
consumption associated with the generation of 
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Free radicaI Superoxide Trypanosoma cruzi 
Oi-, Hz02 and possible OH’ and singlet oxygen 
(iO2) (reviewed in [2]). Although evidence is ac- 
cumulating on the cytotoxicity of these agents to 
parasites when generated by either cell-free model 
systems [7-l 1] or parasiticidal compounds 
[12-161, little is known about the destructive 
potential of cell-derived oxygen metabolites. Intact 
human PMN exposed to antibody-coated 
Trypanosoma cruzi epimastigotes or trypo- 
mastigotes are capable of destroying this target 
[3-5,17,18]. Although the cytotoxic reaction was 
postulated to be dependent on the products of the 
partial reduction of oxygen, the final mediators of 
the destruction were not identified [5]. 
This study provides biochemical and ESR spec- 
troscopic evidence that oxygen consumption and 
production of Oi- and Hz02 are markedly 
stimulated in PMN that are in contact with 
antibody-coated T. cruzi epimastigotes and 
trypomastigotes. 
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2. MATERIALS AND METHODS 
PMN were prepared from fresh heparinized 
human blood by Ficoll-Hypaque separation [19] 
after dextran sedimentation [4]. The con- 
taminating erythrocytes were lysed by hypotonic 
shock. Leukocytes in the PMN suspension were 
90-95% neutrophils. Cell viability, assayed by the 
trypan blue exclusion test, was > 95% after 
purification and assays. Trypanosoma cruzi 
epimastigote [141 and trypomastigote [151 forms 
were prepared as cited. Sera from rabbits im- 
munized with viable T. cruzi epimastigotes in com- 
plete Freund’s adjuvant, agglutinating titre 
> l/4096 for trypsin-treated antigen or l/200 for 
viable cells, and human anti-T. cruzi sera obtained 
from patients with chronic infections were used 
[4,6,20]. The sera were inactivated at 56°C for 
30 min and centrifuged for 1 h at 60000 x g. 
Oxygen consumption by PMN was assayed in a 
Gilson K-IC oxygraph with a Clark-type electrode. 
Hydrogen peroxide was measured by determining 
02 release after the addition of catalase [21]. Pro- 
duction of Oi- was determined with the 
adrenochrome assay [22] by measuring the absorp- 
tion at 480-575 nm using an absorption coeffi- 
cient of 2.96 mM-‘.cm-’ [12]. An Aminco- 
Chance spectrophotometer (American Instrument 
Company, Silver Spring MD) was utilized. Unless 
stated otherwise, all measurements were made at 
37°C. The reactions were recorded under resting 
conditions and after the addition of unsensitized 
T. cruzi or antibody-coated T. cruzi at a 1: 1 
PMN : parasite ratio. Antibody-coated T. cruzi 
were obtained by incubating the parasites with a 
l/200 dilution of anti-T. cruzi serum for 15 min at 
30°C. 
Spin-trapping experiments were carried out us- 
ing 10’ PMN/ml in RPM1 medium containing 
200 mM DMPO (5,5 ’ -dimethyl- 1 -pyrroline-N- 
oxide) and 0.1 mM DETAPAC (diethylene- 
triamine penta-acetic acid). Neither DETAPAC 
(1 mM) nor DMPO (100 mM) affected the resting 
or stimulated rates of oxygen consumption by 
neutrophils [23,24]. After the addition of the 
stimulus (10’ parasites/ml) the suspension was in- 
cubated at 37°C in the presence or absence of 
superoxide dismutase or catalase as indicated. At 
various intervals after the addition of the stimulus 
a portion (0.5 ml) of the cell suspension was 
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transferred to the chamber of a flat cell using a syr- 
inge. The DMPO was purified according to [25]. 
[DMPO] was determined spectrophotometrical- 
ly (6234 =7.7 mM_’ . cm-‘) in ethanol. ESR spectra 
were recorded using a Varian E-9 spectrometer 
with an E23s TM~Io cavity operating at 100 kHz 
field modulation in the first derivative mode. 
3. RESULTS 
To determine if the respiratory burst and 
hydrogen peroxide production by PMN could be 
triggered by contact with antibody-coated 
Trypanosoma cruzi epimastigotes or trypo- 
PMN E-Ab 
I ml” 
Fig.1. Oxygen consumption by PMN in the presence of 
T. cruzi. The arrows indicate the addition of PMN (2 x 
10’ cells/ml), antibody-coated epimastigotes (E-Ab), 
antibody-coated trypomastigotes (T-Ab), epimastigotes 
(E) and trypomastigotes (T) at 2 x 10’ cells/ml, and 
catalase (CAT, 250,ug/ml). The numbers indicate the 
rate of oxygen consumption in nmol.min-’ . 10’ 
PMN-‘. The incubations were at 37°C in a modified 
Krebs-Ringer phosphate medium containing 0.12 M 
NaCl, 5 mM KCI, 10 mM phosphate buffer 
(NazHP04-NaH2P04, pH 7.4), 1 mM Mg2S04, 10 mM 
glucose, and 0.9 mM CaC12. 
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Oxygen consumption and hydrogen peroxide release during ingestion of different Trypanosoma cruzi form? 
Form Oxygen consumption Hydrogen peroxide release 
(nmol. 3 min-’ .2 x lo7 PMN-l)b (nmol. 3 min-’ .2 x IO7 PMN-r)b 
Epimastigote 117.0 k 4.2 26.4 k 3.2 
Trypomastigote 41.1 + 5.3 11.1 + 2.1 
a Parasite-to-PMN ratios were 1: 1; both forms were antibody-coated as in fig.1 and section 2 
b Results are expressed as the mean + SD (3 independent determinations) 
mastigotes, oxygen consumption and Hz02 release 
were measured under conditions where PMN- 
mediated cytotoxicity occurs [5,6]. 
Fig.1 shows the recorded tracings of the 
polarographic assays of oxygen uptake and Hz02 
generation by PMN from human blood in the 
presence of antibody-coated T. cruzi epimastigotes 
(fig.lA) or trypomastigotes (fig.lB). Unstimulated 
cells consumed oxygen at 0.5 f 0.2 nmol/lO’ 
cells. min, a value which agrees with that reported 
in [24]. Oxygen concentration fell rapidly after a 
latency of -30 s in the presence of different 
antibody-coated T. cruzi forms. The effect was 
higher in the presence of antibody-coated T. cruzi 
epimastigotes than in the presence of antibody- 
coated T. cruzi trypomastigotes. Since the rate of 
oxygen consumption depended on the PMN 
preparation, the same PMN preparations were us- 
ed in comparative experiments. Unsensitized T. 
cruzi epimastigotes (fig. 1C) or trypomastigotes 
(fig. 1D) caused significantly less activation of 
PMN. Antibody added separately caused no 
significant activation (not shown). Oxygen con- 
sumption by the concentration of T. cruzi used was 
negligible. The accumulation of Hz02 in the 
medium is indicated by the increase in oxygen con- 
centration after catalase addition. The release of 
Hz02 into the medium accounts for 22-27070 of the 
oxygen consumed (table 1). 
The rate of formation of superoxide anion by 
PMN as detected by adrenochrome formation is il- 
lustrated in fig.2. Addition of PMN did not 
stimulate adrenochrome formation. Further addi- 
tion of antibody-coated T. cruzi epimastigotes 
caused a marked stimulation of adrenochrome for- 
mation, which was inhibited only 50% by superox- 
ide dismutase independently of the time of its addi- 
tion, indicating that not only Oi- is involved in 
adrenochrome formation by this system. There 
was a lag of -30 s before adrenochrome formation 
started. No significant adrenochrome formation 
was observed in incubations containing unsensitiz- 
ed parasites. 
For a more direct demonstration of Oi- and/or 
OH’ production by PMN in the presence of T. 
cruzi, spin-trapping experiments were performed 
with DMPO. With this technique, short-lived 
radical species, such as Oi- and OH’, react with 
‘spin traps’ to yield relatively long-lived nitroxide 
adducts, which may be characterized by electron 
spin resonance spectroscopy. 
FormatIon I 
lmin 
PMN 
1 i 
Fig.2. Adrenochrome formation by PMN on addition of 
T. cruzi epimastigotes. The incubation medium 
contained 1 mM epinephrine and 2 x IO7 PMN/ml. 
Where indicated, antibody-coated epimastigotes (E-Ab) 
or unsensitized epimastigotes (E) at 2 x 10’ cells/ml and 
10 fig/ml superoxide dismutase (SOD) were added. The 
numbers indicate the rate of adrenochrome formation in 
nmol.min-‘. lo7 PMN-‘. Other experimental conditions 
as in fig.1 and section 2. 
27 
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Fig.3. ESR spectra obtained after incubation for 4 min 
at 37°C of: (a) human PMN (10’ cells/ml), DMPO 
(200 mM), and DETAPAC (0.1 mM) with antibody- 
coated T. cruzi epimastigotes (10’ cells/ml; (B) same as 
(A) but unsensitized T. cruzi epimastigotes; (C) same as 
(A) but in the presence of SOD (10 pg/ml); (D) same as 
(A) but in the absence of parasites. The nominal power 
was 20 mW and the modulation amplitude was 1 G. 
Other experimental conditions as in section 2. 
Incubation of PMN with antibody-coated T. 
cruzi epimastigotes (fig.3A) resulted in an ESR 
signal with splitting constants of aN = aH = 15.02 
f 0.16 G and the 1: 2: 2: 1 intensity distribution 
characteristic of the DMPO-hydroxyl radical ad- 
duct [27-291. This signal was not observed when 
either PMN (not shown) or T. cruzi (fig.3D) were 
omitted and was lower when unsensitized T. cruzi 
were used (fig.3B). Superoxide dismutase at a con- 
centration of 10 pg/ml strongly inhibited DMPO- 
hydroxyl radical adduct formation (fig.3C). In 
contrast, catalase at 250pg/ml had no significant 
inhibitory effect. Comparable results were obtain- 
ed with T. cruzi trypomastigotes. 
4. DISCUSSION 
These data demonstrate that contact of PMN 
with antibody-coated T. cruzi triggers the 
respiratory burst. Oxygen consumption, Oi- and 
Hz02 release were stimulated under conditions of 
PMN-mediated killing [5,6]. This stimulation did 
not occur under non-killing conditions when an- 
tibody was omitted. A common mechanism of 
cytotoxicity of human PMN against different T. 
cruzi forms is suggested by the triggering of the 
respiratory burst by antibody-coated epimastigotes 
and trypomastigotes. 
The trypomastigote forms chosen for these ex- 
periments were obtained from the blood of in- 
fected animals and may be coated by antibodies 
developed by the host. However, it has been 
postulated [30] that capping on the surface mem- 
brane of trypomastigotes may represent the 
mechanism by which the parasites escape destruc- 
tion by host antibodies. Accordingly, they did not 
trigger the respiratory burst if they were not prein- 
cubated with antibodies (T-Ab). Such a resistant 
mechanism would thus explain why 
trypomastigotes escape destruction by host PMN 
in vivo and the persistent parasitemia found in 
hosts chronically infected with T. cruzi. 
The latency of -30 s observed for the increase in 
oxygen consumption may indicate that a fixed 
period of time exists between contact of T. cruzi 
with critical portions of the PMN cell membrane 
and the stimulation of the formation of oxygen 
radicals 13 11. 
Evidence of extracellular Hz02 was provided by 
demonstration of an immediate 02 release when 
catalase was added to phagocytizing cells, implying 
an accumulation of Hz02 in the medium. 
Hydrogen peroxide release into the medium was 
observed to parallel the respiratory burst. Taking 
into account the rate of 02 consumption of T. 
cruzi-stimulated neutrophils, 22-27070 of the Hz02 
formed was released into the medium. However, 
this calculation does not take into consideration 
that endogenous catalase or peroxidases may 
destroy Hz02, thus it can be considered only as an 
approximation. 
The irreversible oxidation of epinephrine to 
adrenochrome provides a sensitive assay for Oi- at 
-lo-’ M [22,32]. However, it has been stated that 
the specificity of the reaction appears to be rather 
poor [32]. In our system adrenochrome formation 
was only partially inhibited by superoxide 
dismutase. A more direct assay for superoxide is 
the technique of spin trapping [27-291. Using this 
technique, two groups have detected the DMPO- 
hydroxyl radical adduct with stimulated 
neutrophils and reported that this was proof of 
hydroxyl radical formation by the neutrophils 
[23,26,33]. 
Detection of hydroxyl radical by spin trapping 
28 
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with DMPO has been questioned in systems in 
which the level of hydroxyl radical production is 
< 3% of the rate of superoxide generation [34]. 
The introduction of nitrone spin traps into these 
systems can lead to the de novo production of the 
hydroxyl radical from the decomposition of the 
DMPO-superoxide radical adduct [34]: 
DMPO-OOH - DMPO (diamagnetic product) 
+ ‘OH 
In addition, the DMPO-hydroxyl spin adduct is 
formed by the decomposition of the 
DMPO-superoxide spin adduct [35]: 
DMPO-OOH - DMPO-OH 
Thus, the generation of the DMPO-hydroxyl 
radical adduct by T. cruzi-stimulated neutrophils 
can be interpreted as due to the generation of Oi-. 
In support of this assignment, superoxide 
dismutase completely inhibited the formation of 
the spin adduct, and catalase had no effect on the 
observed spectra. These results show that this 
hydroxyl spin adduct does not arise from hydrogen 
peroxide via either a Fenton, a Haber-Weiss, or 
some other HzOz-dependent reaction [35]. 
The mechanism for detoxifying oxygen species 
in T. crmi is not clear. Protective enzymes such as 
glutathione peroxidase and catalase, which act in 
mammalian tissues to destroy relatively low and 
high concentrations of Hz02, respectively [32], ap- 
pear to be of very little or no metabolic 
significance in T. cruzi [36,37]. The organism is 
particularly sensitive to Oi-- and HzOz-generating 
agents such as naphthoquinones and nitrofurans 
[12-151. This sensitivity may contribute to the 
susceptibility of antibody-coated T. cruzi to the 
cytotoxic effects of PMN leukocytes. 
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